Renovaro (FRA:2Q5) Net Income (Continuing Operations) : €-49.82 Mil (TTM As of Mar. 2024)

View and export this data going back to 2022. Start your Free Trial

What is Renovaro Net Income (Continuing Operations)?

Net Income (Continuing Operations) indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. Renovaro's Net Income (Continuing Operations) for the three months ended in Mar. 2024 was €-15.66 Mil. Its Net Income (Continuing Operations) for the trailing twelve months (TTM) ended in Mar. 2024 was €-49.82 Mil.

Renovaro Net Income (Continuing Operations) Historical Data

The historical data trend for Renovaro's Net Income (Continuing Operations) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Renovaro Net Income (Continuing Operations) Chart

Renovaro Annual Data

Trend

Mar13

Dec14

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Net Income (Continuing Operations)

Get a 7-Day Free Trial

-15.94

-10.14

-22.18

-107.31

-36.63

Renovaro Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Net Income (Continuing Operations)	Get a 7-Day Free Trial															-4.04	-21.41	-8.60	-4.15	-15.66

Renovaro Net Income (Continuing Operations) Calculation

Net Income (Continuing Operations) indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period.

Net Income (Continuing Operations) for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €-49.82 Mil.

Renovaro (FRA:2Q5) Net Income (Continuing Operations) Explanation

Net Income (Continuing Operations) excludes extraordinary items, income from the cumulative effects of accounting changes, non-recurring items, income from tax loss carry forward, and preferred dividends.

Renovaro Net Income (Continuing Operations) Related Terms

Thank you for viewing the detailed overview of Renovaro's Net Income (Continuing Operations) provided by GuruFocus.com. Please click on the following links to see related term pages.

Renovaro (FRA:2Q5) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Renovaro Inc (FRA:2Q5) » Definitions » Net Income (Continuing Operations)

Comparable Companies

Traded in Other Exchanges

RENB:USA 2Q5:Germany

Address

2080 Century Park East, Suite 906, Los Angeles, CA, USA, 90067

Website

https://www.enochianbio.com

Renovaro Biosciences Inc Formerly Enochian BioSciences Inc is a biopharmaceutical company. It is engaged in the research and development of pharmaceutical and biological products for the treatment of HIV, HBV, and cancer with the intent to manufacture said products.

Renovaro (FRA:2Q5) Headlines

No Headlines